コージンバイオ(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 化学 | 177A/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2024/10/04 | 日証協 | 217,300株 | +6.42% | 50,300株 | +22.68% | 221,411株 | +4.04% | 19,400株 | -56.4% |
2024/09/27 | 日証協 | 204,200株 | -1.23% | 41,000株 | +318.37% | 212,811株 | +2.16% | 44,500株 | +485.53% |
2024/09/20 | 日証協 | 206,739株 | +1.72% | 9,800株 | -77.88% | 208,311株 | +0.73% | 7,600株 | -43.7% |
2024/09/13 | 日証協 | 203,239株 | +7.89% | 44,300株 | -33.88% | 206,811株 | +6.54% | 13,500株 | -29.2% |
2024/09/06 | 日証協 | 188,370株 | -5.46% | 67,000株 | +23.98% | 194,111株 | -4.43% | 19,069株 | -43.75% |
2024/08/30 | 日証協 | 199,239株 | -19.73% | 54,039株 | -47.18% | 203,111株 | -24.27% | 33,900株 | -16.51% |
2024/08/23 | 日証協 | 248,200株 | +8.37% | 102,300株 | +40.83% | 268,217株 | +0.6% | 40,606株 | +34.88% |
2024/08/16 | 日証協 | 229,039株 | +16.44% | 72,639株 | +114.27% | 266,617株 | +5.21% | 30,106株 | -21.02% |
2024/08/09 | 日証協 | 196,700株 | -15.83% | 33,900株 | +32.42% | 253,412株 | +7.24% | 38,119株 | -39.21% |
2024/08/02 | 日証協 | 233,700株 | -12.7% | 25,600株 | -79.62% | 236,311株 | -6.01% | 62,710株 | +3.81% |
2024/07/26 | 日証協 | 267,700株 | +39.72% | 125,600株 | -26.25% | 251,411株 | +32.4% | 60,410株 | -74.41% |
2024/07/19 | 日証協 | 191,600株 | +132.52% | 170,300株 | +337.79% | 189,881株 | +76.99% | 236,100株 | +757.61% |
2024/07/12 | 日証協 | 82,400株 | +13.66% | 38,900株 | +92.57% | 107,281株 | +14.92% | 27,530株 | +2.34% |
2024/07/05 | 日証協 | 72,500株 | -24.08% | 20,200株 | -15.13% | 93,351株 | -7.88% | 26,900株 | +80.14% |
2024/06/28 | 日証協 | 95,500株 | -38.51% | 23,800株 | +68.79% | 101,331株 | -23.41% | 14,933株 | -47.44% |
2024/06/21 | 日証協 | 155,300株 | -7.17% | 14,100株 | +74.07% | 132,311株 | -9.26% | 28,410株 | +170.57% |
2024/06/14 | 日証協 | 167,300株 | -7.06% | 8,100株 | -44.52% | 145,811株 | -1.82% | 10,500株 | +19.32% |
2024/06/07 | 日証協 | 180,000株 | +11.73% | 14,600株 | -82.62% | 148,511株 | +10.49% | 8,800株 | -85.43% |
2024/05/31 | 日証協 | 161,100株 | +70.48% | 84,000株 | +298.1% | 134,406株 | -40.05% | 60,405株 | +529.22% |
※株式分割は考慮していませんのでご注意ください。
Page Top